Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study - André, T; de Gramont, A; Vernerey, D (J Clin Oncol, 2015)